9CB-97608-37094
4 vaccinations
7 coded responses
32 check-ins
6 free-text entries
4 call cases
- Sex
- Female
- Age at first dose
- 61-65
- ZIP prefix
- 040 / ME
- Registered
- 2021-03-31
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-16
Dose 1 — Pfizer-BioNTech
-
2021-03-31
Registered in v-safe
-
2021-03-31
Survey response — day 14, dose 1MedDRA: Arthralgia — Feeling: Fair · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Joints in shoulders and knees more painful than usualMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-31
Report sent to call center — day 14, dose 1Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
-
2021-04-06
Dose 2 — Pfizer-BioNTech
- 2021-04-06
-
2021-04-07
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Swelling · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-04-08
Health check-in — days 1–6 daily, dose 2Feeling: Good · Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-04-09
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Headache, Joint pains, Fatigue or tirednessAdult check-in
-
2021-04-10
Health check-in — days 1–6 daily, dose 2Feeling: Good · Headache, Fatigue or tirednessAdult check-in
-
2021-04-11
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Fever · Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-04-12
Health check-in — days 1–6 daily, dose 2Feeling: Good · Chills, Headache, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-04-13
Health check-in — day 7, dose 2Feeling: Fair · Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-04-21
Survey response — day 14, dose 2MedDRA: Arthralgia, Bursitis, Condition aggravated, Fatigue, Pre-existing disease — Feeling: Fair · Be unable to do your normal daily activitiesFree text: Bursitis in right shoulder exacerbated. Avascular necrosis in hips more painful and symptomatic. Ongoing exhaustion.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-28
-
2021-05-04
Survey response — day 28, dose 2MedDRA: Condition aggravated, Pre-existing disease — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Slight exasperation in COPD symptoms requiring increased use of nebulizer treatments.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-05-11
- 2021-05-18
- 2021-07-06
- 2021-10-06
-
2021-11-16
Dose 3 — Pfizer-BioNTechCo-administered: Flu
- 2022-03-16
-
2022-04-06
Survey response — 12 months, dose 2MedDRA: Bacterial infection, Condition aggravated, Infection, Office visit, Pre-existing disease, SARS-CoV-2 test negative, Upper respiratory tract infection — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professionalFree text: Symptoms: Upper respiratory infectionnot COVID per test. Reoccurrence of MRSA, plus another bacterial infection. Symptoms of avascular necrosis have progressed. Severe degenerative progression in both shoulders interfere with ADL. · Healthcare visit (other): Sick visit with regular Pulmonary specialistMedDRA releases: 2024-11 · check-in free text available
-
2022-04-06
Report sent to call center — 12 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr1 call case(s)
- 2022-04-12
-
2022-04-20
Dose 4 — Pfizer-BioNTech
- 2022-04-20
-
2022-04-21
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2022-04-22
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2022-04-23
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Site: Pain · Joint pains, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2022-04-24
Health check-in — days 1–6 daily, dose 4Feeling: Poor · Site: Pain · Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2022-04-25
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Site: Pain · Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2022-04-26
Health check-in — days 1–6 daily, dose 4Feeling: Fair · Joint pains, Muscle or body aches, Fatigue or tirednessAdult check-in
-
2022-04-27
Health check-in — day 7, dose 4Feeling: Fair · Site: Pain · Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
- 2022-05-04
- 2022-05-15
- 2022-05-20
- 2022-05-27
-
2022-06-01
Survey response — day 42, dose 4MedDRA: Condition aggravated, Osteonecrosis, Pre-existing disease — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: symptoms of COPD (bronchictasis) exacerbated, as well as avascular necrosis.MedDRA releases: 2024-11 · check-in free text available
-
2022-07-20
Survey response — 3 months, dose 4MedDRA: Arthralgia, Asthma, Gastrooesophageal reflux disease, Pre-existing disease, Productive cough, Wheezing — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Increased asthma symptoms (increased phlegm and wheezing) and GERD. Extreme joint pain in shoulders, hips and kneesMedDRA releases: 2024-11 · check-in free text available
-
2022-07-20
Report sent to call center — 3 months, dose 4Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2022-07-21
- 2022-07-21
- 2022-07-21
-
2023-04-24
Survey response — 12 months, dose 4MedDRA: Intestinal obstruction, Nephrolithiasis, Pancreatitis — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Emergency room or emergency department visit, HospitalizationMedDRA releases: 2024-11
-
2023-04-24
Report sent to call center — 12 months, dose 4Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · Emergency room or emergency department visit · Hospitalization · 1 call case(s)
- 2023-04-25
- 2023-04-25
- 2023-04-25
- 2023-04-25
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-16 | Pfizer-BioNTech | |
| 2 | 2021-04-06 | Pfizer-BioNTech | |
| 3 | 2021-11-16 | Pfizer-BioNTech | Flu |
| 4 | 2022-04-20 | Pfizer-BioNTech | No |
Call center
4 call center cases
4 unsuccessful
1 wait over 3 months for a first call
Free text
Release 6 — day 14, dose 1
Symptoms: Joints in shoulders and knees more painful than usual
Release 7 — day 14, dose 2
Symptoms: Bursitis in right shoulder exacerbated. Avascular necrosis in hips more painful and symptomatic. Ongoing exhaustion.
Release 8 — day 28, dose 2
Symptoms: Slight exasperation in COPD symptoms requiring increased use of nebulizer treatments.
Release 11 — 12 months, dose 2
Symptoms: Upper respiratory infectionnot COVID per test. Reoccurrence of MRSA, plus another bacterial infection. Symptoms of avascular necrosis have progressed. Severe degenerative progression in both shoulders interfere with ADL.
Healthcare visit (other): Sick visit with regular Pulmonary specialist
Release 11 — day 42, dose 4
Symptoms: symptoms of COPD (bronchictasis) exacerbated, as well as avascular necrosis.
Release 12 — 3 months, dose 4
Symptoms: Increased asthma symptoms (increased phlegm and wheezing) and GERD. Extreme joint pain in shoulders, hips and knees
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Office visit | · | · | ✓ |
| SD | Arthralgia | ✓ | ✓ | ✓ |
| SD | Asthma | · | · | ✓ |
| SD | Bacterial infection | · | · | ✓ |
| SD | Bursitis | ✓ | ✓ | ✓ |
| SD | Condition aggravated | ✓ | ✓ | ✓ |
| SD | Fatigue | ✓ | ✓ | ✓ |
| SD | Gastrooesophageal reflux disease | · | · | ✓ |
| SD | Infection | · | · | ✓ |
| SD | Intestinal obstruction | · | · | ✓ |
| SD | Nephrolithiasis | · | · | ✓ |
| SD | Osteonecrosis | · | · | ✓ |
| SD | Pancreatitis | · | · | ✓ |
| SD | Pre-existing disease | ✓ | ✓ | ✓ |
| SD | Productive cough | · | · | ✓ |
| SD | SARS-CoV-2 test negative | · | · | ✓ |
| SD | Upper respiratory tract infection | · | · | ✓ |
| SD | Wheezing | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release